- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06909331
Accuracy of Current Techniques in Quantifying Ketone Levels
March 27, 2025 updated by: Augusta University
The purpose of this study is to determine the accuracy of current measuring techniques used to detect physiological ketone levels.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30909
- Augusta University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-35 years
Exclusion Criteria:
- taking medications that affect blood pressure, insulin, or renal function, having meta-bolic syndrome factors such as type 2 diabetes, being pregnant, and/or indicating a pre-existing health condition on the health history questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo drink
They were provided a placebo drink that was color, calorie and flavor-matched to the experimental drink.
|
Participants consumed a placebo drink that was flavor, color and calorie matched to the experimental drink.
|
|
Experimental: Experimental supplement
They were provided an ketone salt drink.
|
Exogenous ketone salt supplement will be taken once to determine acute circulating levels of beta-hydroxybuyrate and acetoacetate compared to a control supplement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Circulating beta-hydroxybutyrate
Time Frame: 30 minutes after consuming the drink
|
Circulating beta-hydroxybutyrate levels measured by ketone meters and GC/MS
|
30 minutes after consuming the drink
|
|
Circulating acetoacetate levels
Time Frame: 30 minutes after consuming the drink
|
30 minutes after consuming the drink
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2019
Primary Completion (Actual)
May 30, 2019
Study Completion (Actual)
December 15, 2019
Study Registration Dates
First Submitted
March 27, 2025
First Submitted That Met QC Criteria
March 27, 2025
First Posted (Actual)
April 3, 2025
Study Record Updates
Last Update Posted (Actual)
April 3, 2025
Last Update Submitted That Met QC Criteria
March 27, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- IRBnet: 1317538
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placebo - Control
-
University of Alabama at BirminghamRecruitingPlacebo - Control | Ketone MonoesterUnited States
-
Liverpool John Moores UniversityCompletedPlacebo - Control | No Pill | CaffineUnited Kingdom
-
Salisbury UniversityNot yet recruitingPlacebo - Control | Delfi Cuff | FitcuffUnited States
-
Liverpool John Moores UniversityActive, not recruitingCaffeine | Placebo - Control | No PillUnited Kingdom
-
University of MaiaCompletedIntermittent Pneumatic Compression | Placebo - ControlPortugal
-
Center for Disease Control and Prevention, Henan...UnknownRandomized | Double-blind | Placebo Control Design
-
Gabriella GobbiNot yet recruitingHealthy Participants | Psilocybin | Placebo - Control
-
Liverpool John Moores UniversityEnrolling by invitationCaffeine | Placebo - Control | No PillUnited Kingdom
-
Northern Arizona UniversityNot yet recruitingExperimental | Placebo - ControlUnited States
-
YAARA TABIBNot yet recruitingHysteroscopy / Methods | Placebo - Control | Lidocaine Infusion
Clinical Trials on Placebo drink solution
-
Wageningen UniversityMaastricht University Medical Center; Top Institute Food and NutritionCompleted
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
Virginia Polytechnic Institute and State UniversityCompletedCardiovascular Risk FactorUnited States
-
Virginia Polytechnic Institute and State UniversityCompletedFood Preferences | Appetitive BehaviorUnited States
-
University of California, RiversideA1CantusNot yet recruiting
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Maastricht University Medical CenterTop Institute Food and NutritionCompletedMuscle Loss in ElderlyNetherlands
-
University of LimerickCompleted